![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: DDX1 |
Gene summary for DDX1 |
![]() |
Gene information | Species | Human | Gene symbol | DDX1 | Gene ID | 1653 |
Gene name | DEAD-box helicase 1 | |
Gene Alias | DBP-RB | |
Cytomap | 2p24.3 | |
Gene Type | protein-coding | GO ID | GO:0000245 | UniProtAcc | A3RJH1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1653 | DDX1 | LZE2T | Human | Esophagus | ESCC | 1.99e-02 | 4.31e-01 | 0.082 |
1653 | DDX1 | LZE4T | Human | Esophagus | ESCC | 1.19e-10 | 4.16e-01 | 0.0811 |
1653 | DDX1 | LZE7T | Human | Esophagus | ESCC | 3.17e-05 | 3.15e-01 | 0.0667 |
1653 | DDX1 | LZE8T | Human | Esophagus | ESCC | 8.09e-03 | 7.79e-02 | 0.067 |
1653 | DDX1 | LZE20T | Human | Esophagus | ESCC | 1.02e-04 | 4.22e-02 | 0.0662 |
1653 | DDX1 | LZE22T | Human | Esophagus | ESCC | 7.06e-03 | 3.14e-01 | 0.068 |
1653 | DDX1 | LZE24T | Human | Esophagus | ESCC | 1.96e-08 | 2.56e-01 | 0.0596 |
1653 | DDX1 | P1T-E | Human | Esophagus | ESCC | 7.30e-06 | 3.18e-01 | 0.0875 |
1653 | DDX1 | P2T-E | Human | Esophagus | ESCC | 3.19e-30 | 6.22e-01 | 0.1177 |
1653 | DDX1 | P4T-E | Human | Esophagus | ESCC | 1.57e-22 | 6.00e-01 | 0.1323 |
1653 | DDX1 | P5T-E | Human | Esophagus | ESCC | 5.32e-13 | 2.61e-01 | 0.1327 |
1653 | DDX1 | P8T-E | Human | Esophagus | ESCC | 2.45e-21 | 3.62e-01 | 0.0889 |
1653 | DDX1 | P9T-E | Human | Esophagus | ESCC | 3.80e-15 | 3.76e-01 | 0.1131 |
1653 | DDX1 | P10T-E | Human | Esophagus | ESCC | 2.64e-36 | 5.99e-01 | 0.116 |
1653 | DDX1 | P11T-E | Human | Esophagus | ESCC | 1.50e-13 | 5.19e-01 | 0.1426 |
1653 | DDX1 | P12T-E | Human | Esophagus | ESCC | 1.70e-33 | 6.09e-01 | 0.1122 |
1653 | DDX1 | P15T-E | Human | Esophagus | ESCC | 1.73e-13 | 1.94e-01 | 0.1149 |
1653 | DDX1 | P16T-E | Human | Esophagus | ESCC | 1.53e-13 | 2.62e-01 | 0.1153 |
1653 | DDX1 | P17T-E | Human | Esophagus | ESCC | 3.51e-06 | 2.66e-01 | 0.1278 |
1653 | DDX1 | P19T-E | Human | Esophagus | ESCC | 7.37e-04 | 4.47e-01 | 0.1662 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000636421 | Liver | HCC | rRNA processing | 185/7958 | 225/18723 | 8.14e-35 | 6.45e-32 | 185 |
GO:00346601 | Liver | HCC | ncRNA metabolic process | 332/7958 | 485/18723 | 1.48e-31 | 7.80e-29 | 332 |
GO:000037522 | Liver | HCC | RNA splicing, via transesterification reactions | 228/7958 | 324/18723 | 1.47e-24 | 4.06e-22 | 228 |
GO:000037722 | Liver | HCC | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 224/7958 | 320/18723 | 1.16e-23 | 2.62e-21 | 224 |
GO:000039822 | Liver | HCC | mRNA splicing, via spliceosome | 224/7958 | 320/18723 | 1.16e-23 | 2.62e-21 | 224 |
GO:190331121 | Liver | HCC | regulation of mRNA metabolic process | 205/7958 | 288/18723 | 3.38e-23 | 6.90e-21 | 205 |
GO:000640321 | Liver | HCC | RNA localization | 151/7958 | 201/18723 | 3.72e-21 | 5.89e-19 | 151 |
GO:000691322 | Liver | HCC | nucleocytoplasmic transport | 208/7958 | 301/18723 | 5.51e-21 | 8.12e-19 | 208 |
GO:005116922 | Liver | HCC | nuclear transport | 208/7958 | 301/18723 | 5.51e-21 | 8.12e-19 | 208 |
GO:007182622 | Liver | HCC | ribonucleoprotein complex subunit organization | 159/7958 | 227/18723 | 3.14e-17 | 3.06e-15 | 159 |
GO:004348422 | Liver | HCC | regulation of RNA splicing | 113/7958 | 148/18723 | 4.32e-17 | 4.15e-15 | 113 |
GO:005068421 | Liver | HCC | regulation of mRNA processing | 106/7958 | 137/18723 | 7.64e-17 | 7.12e-15 | 106 |
GO:000641722 | Liver | HCC | regulation of translation | 287/7958 | 468/18723 | 8.79e-17 | 8.08e-15 | 287 |
GO:000641322 | Liver | HCC | translational initiation | 94/7958 | 118/18723 | 1.39e-16 | 1.24e-14 | 94 |
GO:004227322 | Liver | HCC | ribosomal large subunit biogenesis | 64/7958 | 72/18723 | 2.31e-16 | 2.03e-14 | 64 |
GO:002261822 | Liver | HCC | ribonucleoprotein complex assembly | 153/7958 | 220/18723 | 3.44e-16 | 2.91e-14 | 153 |
GO:005123621 | Liver | HCC | establishment of RNA localization | 121/7958 | 166/18723 | 1.61e-15 | 1.19e-13 | 121 |
GO:005116822 | Liver | HCC | nuclear export | 113/7958 | 154/18723 | 6.30e-15 | 4.39e-13 | 113 |
GO:005065711 | Liver | HCC | nucleic acid transport | 118/7958 | 163/18723 | 8.30e-15 | 5.60e-13 | 118 |
GO:005065811 | Liver | HCC | RNA transport | 118/7958 | 163/18723 | 8.30e-15 | 5.60e-13 | 118 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
DDX1 | SNV | Missense_Mutation | c.2095N>A | p.Gly699Arg | p.G699R | Q92499 | protein_coding | tolerated(0.22) | benign(0.303) | TCGA-BH-A2L8-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | CR | |
DDX1 | SNV | Missense_Mutation | novel | c.1433G>C | p.Gly478Ala | p.G478A | Q92499 | protein_coding | tolerated(0.09) | benign(0.255) | TCGA-E2-A574-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
DDX1 | SNV | Missense_Mutation | novel | c.449C>T | p.Ser150Phe | p.S150F | Q92499 | protein_coding | deleterious(0) | probably_damaging(0.974) | TCGA-EW-A423-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | anastrozole | SD |
DDX1 | SNV | Missense_Mutation | novel | c.351G>T | p.Lys117Asn | p.K117N | Q92499 | protein_coding | tolerated(0.06) | possibly_damaging(0.787) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
DDX1 | SNV | Missense_Mutation | c.1925N>A | p.Arg642Lys | p.R642K | Q92499 | protein_coding | tolerated(0.82) | benign(0.003) | TCGA-IR-A3LK-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | PD | |
DDX1 | SNV | Missense_Mutation | c.238N>G | p.Thr80Ala | p.T80A | Q92499 | protein_coding | tolerated(0.59) | benign(0) | TCGA-AA-3811-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
DDX1 | SNV | Missense_Mutation | c.387G>A | p.Met129Ile | p.M129I | Q92499 | protein_coding | tolerated(0.4) | benign(0.003) | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
DDX1 | SNV | Missense_Mutation | c.1757N>G | p.Tyr586Cys | p.Y586C | Q92499 | protein_coding | deleterious(0) | probably_damaging(0.962) | TCGA-AD-6889-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | xeloda | PD | |
DDX1 | SNV | Missense_Mutation | novel | c.1274N>C | p.Phe425Ser | p.F425S | Q92499 | protein_coding | tolerated(0.05) | probably_damaging(0.999) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
DDX1 | SNV | Missense_Mutation | c.1859N>T | p.Ala620Val | p.A620V | Q92499 | protein_coding | deleterious(0.01) | possibly_damaging(0.776) | TCGA-CK-5913-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |